Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Protalix BioTherapeutics added to key Russell indexes, likely boosting visibility and investment interest.
Protalix BioTherapeutics, a biopharmaceutical company specializing in therapeutic protein production, has been added to the Russell 3000 and 2000 Indexes.
This inclusion, following the annual reconstitution of these indexes, is expected to increase the company's visibility among investment managers and institutional investors.
The Russell indexes are widely used benchmarks, with trillions of dollars in assets tracking them.
3 Articles
Protalix BioTherapeutics se agregó a los índices clave de Russell, lo que probablemente aumentó la visibilidad y el interés de las inversiones.